Page last updated: 2024-08-16

rolipram and rs 25344

rolipram has been researched along with rs 25344 in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bjornsson, JM; Burgin, AB; Gurney, ME; Hagen, T; Hrafnsdottir, S; Kiselyov, AS; Magnusson, OT; Singh, J; Staker, BL; Stewart, LJ; Thorsteinsdottir, M; Witte, P1
Abraham, A; Adams, DR; Allcock, RW; Anthony, D; Baillie, GS; Bogum, J; Christian, F; Day, JP; Houslay, DM; Houslay, MD; Huston, E; Jiang, Z; Klussmann, E; Lindsay, B; Martin, EK; Rae, RL; Riddell, T; Rosair, GM; Sookup, S1
de Esch, IJ; de Graaf, C; Jansen, C; Kanev, GK; Kooistra, AJ; Leurs, R1
Kim, E; Kim, JH; Kim, SH; Nam, G; Rhee, CK; Shin, JH; Yoon, CM1

Other Studies

4 other study(ies) available for rolipram and rs 25344

ArticleYear
Design of phosphodiesterase 4D (PDE4D) allosteric modulators for enhancing cognition with improved safety.
    Nature biotechnology, 2010, Volume: 28, Issue:1

    Topics: Allosteric Regulation; Amino Acid Sequence; Animals; Behavior, Animal; Benzhydryl Compounds; Biological Assay; Catalytic Domain; Cell Line; Cognition; Crystallography, X-Ray; Cyclic Nucleotide Phosphodiesterases, Type 4; Disease Models, Animal; Drug Design; Humans; Kinetics; Mice; Models, Molecular; Molecular Sequence Data; Phenylurea Compounds; Phosphodiesterase 4 Inhibitors; Phosphodiesterase Inhibitors; Protein Structure, Tertiary; Structure-Activity Relationship; Vomiting

2010
Elucidation of a structural basis for the inhibitor-driven, p62 (SQSTM1)-dependent intracellular redistribution of cAMP phosphodiesterase-4A4 (PDE4A4).
    Journal of medicinal chemistry, 2011, May-12, Volume: 54, Issue:9

    Topics: Adaptor Proteins, Signal Transducing; Animals; Catalytic Domain; CHO Cells; Cricetinae; Cricetulus; Crystallography, X-Ray; Cyclic Nucleotide Phosphodiesterases, Type 4; Isoenzymes; Models, Molecular; Phosphodiesterase 4 Inhibitors; Pyridines; Rolipram; Sequestosome-1 Protein; Spiro Compounds; Stereoisomerism; Structure-Activity Relationship; Xanthines

2011
PDEStrIAn: A Phosphodiesterase Structure and Ligand Interaction Annotated Database As a Tool for Structure-Based Drug Design.
    Journal of medicinal chemistry, 2016, Aug-11, Volume: 59, Issue:15

    Topics: Databases, Protein; Dose-Response Relationship, Drug; Drug Design; Humans; Ligands; Models, Molecular; Molecular Structure; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Structure-Activity Relationship

2016
Syntheses and evaluation of pyrido[2,3-dlpyrimidine-2,4-diones as PDE 4 inhibitors.
    Bioorganic & medicinal chemistry letters, 2001, Mar-12, Volume: 11, Issue:5

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Biological Assay; Cyclic Nucleotide Phosphodiesterases, Type 4; Humans; Molecular Structure; Phosphodiesterase Inhibitors; Pyrimidines; Quinazolines; Rats; Rolipram

2001
chemdatabank.com